Letrozole API Powder

Letrozole API Powder Aromatase Inhibitor for Breast Cancer & Infertility Formulations Narix Pharmaceuticals Narix Pharmaceuticals supplies Letrozole API Powder, a non-steroidal aromatase inhibitor used for manufacturing Femara tablets the leading adjuvant therapy for HR+ breast cancer in postmenopausal women and widely used for ovulation induction in infertility. Technical Specifications: CAS Number: 112809-51-5 Purity: Greater than 99% Grade Standard: USP Form: Powder MOQ: 1 Kg Applications: Breast cancer aromatase inhibitor tablets, ovulation induction tablets, PCOS infertility treatment Storage: Cool, dry, sealed storage #LetrozoleAPI #AromataseInhibitorAPI #BreastCancerAPIManufacturer #FemaraAPIManufacturer #OvulationInductionAPI #NarixPharmaceuticals #WHOGMPCertified About the Company GST Registration Date: 2023 Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 1.5 - 5 Cr company-description: Established in the year of 2016, We "Narix Pharmaceuticals Private Limited" are Wholesaler Exporter, Distributor, Importer and Supplier of an Pharmaceutical Tablets, Oral Jelly, Pharmaceutical Capsules, Pharmaceutical Soap, Pharmaceutical Cream, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.For our accomplishment story, we are grateful to our Mr. Naman, whose continual backing and direction have been useful to us for attaining exponential development in the current market.